Contraception in Perimenopause: An India Guide for Your 40s

• You can still conceive in perimenopause. Contraception is needed until menopause is confirmed — 12 months with no periods — or until age 55, whichever comes first.
• Combined pills are only for healthy non-smokers without cardiovascular risk; after the mid-40s, progestogen-only and non-hormonal methods are usually safer.
• The Mirena (hormonal IUD) is often the standout choice: it prevents pregnancy, cuts heavy bleeding by around 90%, and can become the progestogen part of HRT after menopause.
• Hormonal methods can hide your periods, so the 12-month rule is hard to read on them — a doctor may check FSH after age 50 or simply advise continuing until 55.
• HRT is not contraception. If you start HRT while still potentially fertile, you still need a contraceptive method.
• In India, copper IUD and sterilisation are free in the public system; Mirena (around ₹16,500–27,000) is the main private upgrade for perimenopausal women.

Yes. Fertility falls steeply through your 40s, but it does not switch off until your ovaries stop releasing eggs for good — and that is only confirmed in hindsight, after 12 months without a period. A 45-year-old who still has the occasional period can still ovulate, and pregnancies do happen in this age group.

For couples actively trying, the chance of conceiving in any one cycle is roughly 1 in 5 at age 25, about 1 in 10 at 35, around 5% at 40, and only 1–3% at 45. For a perimenopausal woman having occasional unprotected sex — not timing it — the per-act risk is much lower, but the cumulative risk over a year is still real: in the order of 5–15% a year between 40 and 44, and 2–5% between 45 and 50.

This is why so many unplanned pregnancies in midlife happen on the quiet assumption that "it can't happen now." If your cycles have become unpredictable, it can also be genuinely confusing to tell a late period from early menopause — our guide on telling pregnancy apart from menopause walks through how to read the signs and when to test.

Pregnancy outcomes also matter here. Compared with younger women, pregnancy after 40 carries a higher risk of miscarriage, chromosomal conditions such as Down syndrome (around 1 in 100 at 40, rising to about 1 in 30 by 45), gestational diabetes, high blood pressure in pregnancy, preterm birth, caesarean delivery and stillbirth. None of this is meant to alarm — plenty of healthy babies are born to women in their 40s — but it does explain why reliable contraception, when you do not want a pregnancy, is a genuine health priority and not just a convenience.

Perimenopause is essentially your ovaries winding down unevenly. Early on, cycles often get a little shorter (25–27 days) and more variable. In the middle stretch they become genuinely irregular — some short, some long, the odd one skipped, flow lighter one month and heavier the next. In the final year or two, gaps stretch to months until periods stop altogether. Ovulation becomes erratic but can still occur, which is exactly why fertility stays unpredictable.

Symptoms tend to ramp up alongside this. Heavy menstrual bleeding is one of the most common complaints, often made worse by fibroids, which frequently grow in these years. Periods may also become more painful, premenstrual symptoms can intensify, and heavy bleeding can quietly drain your iron and leave you anaemic and exhausted.

Hot flushes and night sweats usually begin in perimenopause and build as menopause nears, driven by the brain's temperature centre reacting to swinging oestrogen. Disturbed sleep, mood changes and early genitourinary symptoms (vaginal dryness, lower libido, more frequent urinary infections) can all appear in this window too.

Here is the useful part: your contraceptive choice can work for or against these symptoms. The Mirena hormonal IUD is licensed to treat heavy bleeding and is often ideal in perimenopause, cutting blood loss by around 90% within 6–12 months while also preventing pregnancy. Combined hormonal methods, in women without contraindications, can steady cycles and damp down hot flushes. Progestogen-only methods usually make periods much lighter or stop them. Non-hormonal options (copper IUD, condoms, Saheli) don't treat symptoms but also don't interfere with the natural transition or with separate symptom treatments. For the bigger picture on this life stage, our overview of perimenopause in Indian women puts the contraceptive decision in context.

The standard rule is simple to state: stop only after menopause is confirmed, defined as 12 consecutive months with no bleeding at all — not just longer gaps or the odd skipped period, but a complete absence of bleeding for a full year. Until then, pregnancy remains possible even with very irregular cycles. This 12-month threshold is the consensus across international and Indian guidance.

There is one practical shortcut. Many guidelines accept that contraception can be stopped at age 55 even without a confirmed 12-month gap, because spontaneous pregnancy beyond 55 is exceedingly rare. Below 55, the 12-month rule stands.

The complication is that hormonal methods can mask your natural pattern, making the 12-month rule hard to read:

Where it is hard to tell, a doctor may stop the hormonal method for about 6 weeks and check a blood FSH (follicle-stimulating hormone) level: a result above 30 IU/L suggests you are postmenopausal, and it can be repeated 6–12 weeks later to confirm. Use condoms during that testing window. For most women, though, it is simpler to just continue contraception until 55 (or until a clear 12-month no-period gap after age 50).

The right method in perimenopause depends heavily on your age, your cardiovascular risk and any medical conditions — not on age alone. The big picture breaks down into three groups.

Combined hormonal methods (combined pill, patch, vaginal ring) carry the most age-related caveats. In a genuinely low-risk woman — a non-smoker with normal blood pressure and BMI, no clotting history and no migraine with aura — they can be used up to 50, sometimes to 55 with monitoring, and they bring a real bonus: steadier cycles and fewer hot flushes. But the risks rise with age and with any risk factor. Smoking after 35, high blood pressure, diabetes, obesity, migraine with aura or a clotting history all weigh against combined methods, and in practice most women with these features should choose something else. If you want to understand the trade-offs in depth, see our guide to combined and mini-pills in India.

Progestogen-only methods (mini-pill, DMPA injection, implant, Mirena) suit most perimenopausal women because their cardiovascular safety profile is far gentler, even with risk factors. The Mirena stands out and gets its own section below. The contraceptive implant and the DMPA injection are also reasonable long-acting choices.

Non-hormonal methods (copper IUD, condoms, diaphragm, Saheli, sterilisation) work throughout perimenopause and are the natural fit if you prefer to avoid hormones or can't use them. A single copper IUD covers up to 10 years — often enough to carry one insertion right through perimenopause to menopause. Our non-hormonal birth control guide and the copper-vs-Mirena comparison lay out the options side by side.

A simple way to decide: your age and risk factors set which methods are safe; your bleeding pattern and symptoms decide which add a therapeutic bonus; the years of cover you still need favour long-acting options; and access and preference settle the rest. For women with meaningful cardiovascular risk, the Mirena or a non-hormonal method is usually safest. Without those risks, the full menu stays open.

The Mirena (a levonorgestrel-releasing intrauterine system, or LNG-IUS) deserves a closer look because for many perimenopausal women it is the single most useful device available. It does three jobs at once: highly reliable contraception, treatment for heavy bleeding, and a seamless bridge into HRT after menopause. It releases about 20 micrograms of levonorgestrel a day directly into the uterus over its 5-year licensed life (with growing evidence supporting up to 7 years), so the hormone acts mostly locally and systemic exposure stays low.

As contraception it is excellent — fewer than 1 pregnancy per 100 women a year, on par with the copper IUD and sterilisation and better than the pill, patch or ring. That puts it among the most reliable options you can choose.

For heavy bleeding it is licensed treatment and genuinely effective, typically cutting menstrual blood loss by about 90% within 6–12 months. In perimenopause, where heavy periods are so common and fibroids often add to them, the Mirena frequently spares women from procedures such as endometrial ablation or hysterectomy. Whether you have it fitted mainly for bleeding (with contraception as the bonus) or mainly for contraception (with lighter periods as the bonus), the dual benefit is welcome. It usually eases painful periods too, including pain from adenomyosis — see our guide on adenomyosis treatment options.

The HRT bridge is the clever part. After menopause, a woman with a uterus who takes oestrogen for symptoms or bone health also needs a progestogen to protect the womb lining from cancer. The Mirena delivers that progestogen locally, exactly where it is needed, while avoiding the whole-body progestogen many women find hard to tolerate. So if you already have a Mirena in place as you reach menopause, it can simply stay put and oestrogen-only HRT can be added on top — no separate progestogen tablet required. Replaced every 5 years (or up to 7 where supported), it can carry you from perimenopause well into the early postmenopausal years when HRT use is most common. To see how oestrogen and progestogen are matched to symptoms, read our piece on tailoring HRT to your symptoms.

Permanent sterilisation — tubal ligation for women or vasectomy for men — is a fair option for couples who are completely certain their family is complete. It removes all future contraceptive decisions and the small ongoing failure risk that every reversible method carries. But the maths is different in perimenopause: with perhaps only 5–10 fertile years left, the procedure buys fewer years of protection than it would for a younger couple.

That changes the cost-benefit picture. A copper IUD gives up to 10 years of equally reliable contraception from a single insertion, at far lower cost and with no surgery — for many couples it covers the whole remaining fertile window just as well, while keeping reversibility in reserve.

If you do lean towards sterilisation, vasectomy is usually the more sensible choice. For a man in his 40s or 50s it remains a quick, low-risk outpatient procedure under local anaesthetic, with the same safety profile as at any age. No-scalpel vasectomy (NSV) is free at government District Hospitals under Mission Parivar Vikas with a cash incentive of around ₹2,000, or roughly ₹10,000–30,000 privately. Our vasectomy myths guide covers what actually happens.

Female sterilisation (tubectomy) is a bigger undertaking — a laparoscopic day procedure with slightly higher anaesthetic risk at older ages, costing roughly ₹15,000–60,000 privately or free at government facilities with a small incentive. Our guide to tubal ligation in India explains the procedure and recovery. The honest framing: sterilisation suits some couples, but in perimenopause a copper IUD often delivers the same practical benefit with less commitment, so it is worth weighing both carefully.

One of the best things about choosing contraception in perimenopause is that the right method can do double duty on symptoms. Here is how the main ones line up.

Heavy bleeding affects up to a third of perimenopausal women. The Mirena is the most effective answer, cutting blood loss by around 90% while also covering contraception. Combined methods reduce flow more modestly (if you have no contraindications), and progestogen-only methods such as DMPA or the implant often stop periods altogether. If heavy bleeding is your main problem, the Mirena is usually first-line.

Hot flushes and night sweats respond well to combined hormonal methods in women without contraindications — the oestrogen dose in a combined pill is actually higher than in standard HRT and damps flushes effectively. If you can't use combined methods, manage flushes separately: keep cool, avoid triggers, and ask your doctor about non-hormonal medicines (certain SSRIs/SNRIs or gabapentin) alongside a progestogen-only or non-hormonal contraceptive. Keep cool, avoid spicy-food and caffeine triggers, and dress in light cotton layers for the Indian climate.

Mood is more individual. Some women feel steadier on combined methods that smooth out hormone swings; others feel worse on hormones. It can take a trial and a switch to find your fit, and non-hormonal methods sidestep the question entirely. Sleep often improves indirectly when flushes are controlled, on top of good sleep habits.

Genitourinary symptoms — vaginal dryness, lower libido, recurrent urinary infections — are best treated locally (vaginal oestrogen, lubricants, targeted UTI care) rather than relying on contraception, though systemic oestrogen in a combined pill can help tissue health a little. Our guide on vaginal atrophy goes deeper.

Bone health is worth a mention: combined methods maintain oestrogen and support bone density, while the DMPA injection has a small, usually reversible negative effect on bone with long-term use. Other methods are bone-neutral. The realistic takeaway is that in perimenopause, your contraceptive choice is part of your whole midlife health plan — picked to cover pregnancy and your most bothersome symptoms together.

The same public and private channels that serve younger women cover perimenopausal contraception, with a few age-specific points worth knowing.

Through the public sector and the National Family Planning Programme you can access, free of charge: the copper IUD (Cu-T 380A) at any PHC, CHC, District Hospital or Medical College; tubal ligation at District Hospitals with a cash incentive of roughly ₹600–1,400; NSV for the husband with a ₹2,000 incentive; the DMPA injection (Antara); combined pills (Mala-N, Mala-D); and condoms (Nirodh) — with counselling from ANMs, Medical Officers and ASHA workers. This covers the essentials across all income levels.

In the private sector the standout option for perimenopausal women is the Mirena, available at major chains (Apollo, Cloudnine, Fortis, Manipal, Max) and established gynaecology practices for roughly ₹16,500–27,000 all-in, given its multi-purpose benefits. Other private options: copper IUD (₹300–2,000), implant (₹13,500–30,000), Saheli/Centchroman (₹50–150 a month), tubal ligation (₹15,000–60,000) and vasectomy (₹10,000–30,000).

On insurance: government schemes such as Ayushman Bharat and various state schemes usually cover family-planning services including IUD insertion and sterilisation. Private health insurance varies — some policies cover contraception when there is a medical indication (for example, a Mirena fitted to treat heavy bleeding), others don't cover routine contraception. If heavy bleeding is part of your picture, it is worth asking whether the Mirena can be covered as treatment.

A practical tip: book a focused gynaecology consult specifically about perimenopausal contraception, rather than tacking it onto a general check-up. Ask your doctor to join the dots between your method, your bleeding and symptoms, your cardiovascular risk, any plan for HRT later, and how many more years of cover you realistically need — then choose with that multi-year window in mind. In most metro settings the Mirena or copper IUD give excellent long cover; in the public system the copper IUD and sterilisation are well supported.

A few specific scenarios come up often enough in perimenopause to plan ahead for.

Starting HRT while still fertile. Some women begin HRT for flushes before menopause is confirmed. Crucially, HRT is not contraception — its hormone doses are lower than in the combined pill and don't reliably stop ovulation, so you still need a method. The neatest solution is a Mirena, which provides contraception and doubles as the progestogen part of HRT; alternatives are a copper IUD or condoms used alongside HRT.

Wanting to conceive in your 40s. If you do want a pregnancy, simply stop your method — fertility returns quickly after any reversible method. Conception may take longer at this age (often 6–12 months in the early 40s, longer later), so it's reasonable to seek a fertility review after about 6 months of trying once you're over 35.

Significant fibroids with heavy bleeding. Fibroids are very common by 50 and often drive the heavy bleeding of perimenopause. A Mirena usually helps both bleeding and contraception, though insertion can be harder with large or cavity-distorting fibroids; a copper IUD may not sit well if the cavity is distorted; and surgical options (uterine artery embolisation, myomectomy, hysterectomy) treat fibroid bleeding more definitively — after hysterectomy, contraception is no longer needed. Plan this with your gynaecologist.

New cardiovascular risk factors. If high blood pressure, raised cholesterol or weight gain appear during these years, revisit your method. Combined methods become less appropriate as risk rises — switching to a progestogen-only or non-hormonal method, often the Mirena, keeps you protected without adding cardiovascular load. The same logic applies to migraine: if you develop migraine with aura, combined methods are best avoided.

A history of breast cancer. With current or recent breast cancer, hormonal contraception — combined and progestogen-only, including the Mirena — is generally avoided because of concerns about hormonal influence on recurrence. Non-hormonal options (copper IUD, condoms, Saheli, sterilisation) are appropriate, decided together with your oncology and gynaecology teams.

Pulling it together, here is a practical order to think it through with your doctor.

Start with how much pregnancy risk you can accept. Are you firmly against a pregnancy now, or would an unplanned one be unwelcome but manageable? This sets how much reliability you need.

Next, weigh your cardiovascular and medical risks — smoking, blood pressure, diabetes, weight, clotting history, migraine with aura, breast cancer. As these accumulate with age, combined methods fall out of favour and progestogen-only or non-hormonal methods come to the fore.

Then factor in symptoms you'd like help with: heavy bleeding (Mirena shines), hot flushes (combined methods, if safe), painful periods (Mirena helps), and mood (which may steer you towards or away from hormones).

Consider whether your family is genuinely complete (which opens the door to sterilisation), how many more years of cover you need (the Mirena's 5–7 years, the copper IUD's 10 years and sterilisation's permanence all suit the multi-year window), and whether you expect to use HRT later (where the Mirena's seamless bridge is a real plus). Fertility returns quickly after stopping any reversible method if pregnancy is still on the table.

Putting it together: for most women without major risk factors who want reliable, long-acting, multi-purpose cover, the Mirena leads. Where hormones are best avoided, the copper IUD gives 10 hormone-free years. Where a family is firmly complete, sterilisation — usually vasectomy — is an option, though a copper IUD often serves the same purpose with reversibility kept. And for specific preferences, Saheli, combined methods (if safe) or others may fit.

Finally, plan past the method itself: expect to confirm menopause (12 months with no periods, or age 55) and stop contraception then, line up an HRT transition if relevant, and keep up the rest of midlife care — blood pressure, cholesterol, cancer screening and bone health. Your contraceptive choice is one piece of a fuller perimenopausal health plan, best mapped out with your gynaecologist.

• Faculty of Sexual & Reproductive Healthcare (FSRH) — Contraception for Women Aged Over 40 Years
• NHS — Contraception and the menopause
• American College of Obstetricians and Gynecologists (ACOG) — Perimenopausal Bleeding and Bleeding After Menopause
• World Health Organization — Medical Eligibility Criteria for Contraceptive Use (5th edition)
• Ministry of Health and Family Welfare, Government of India — Family Planning (Mission Parivar Vikas)
• Indian Menopause Society — Clinical Practice Guidelines on Menopause